File(s) under permanent embargo
Early SARS-CoV-2-associated acute transverse myelitis: A case for neurotropism?
journal contributionposted on 24.11.2022, 03:53 authored by IF Lu, JS Cornish, A Ashok, SK Chen, Eugene AthanEugene Athan, Andrew HughesAndrew Hughes
There are increasing reports of immune-mediated and para-infectious syndromes beyond the well-known respiratory manifestations of severe-acute-respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, the spectrum of severe neurological sequelae of SARS-CoV-2 remains undefined. We present the case of a 66-year-old female with rapidly progressive lower limb neurology 3 days post SARS-CoV-2 infection. Clinical and radiological findings were in keeping with transverse myelitis and treatment success was achieved with methylprednisolone and remdesivir. This report will discuss the associations between SARS-CoV-2 and acute transverse myelitis. We believe this is one of few described cases of early SARS-CoV-2-associated transverse myelitis secondary to neurotropism and the first successfully treated with the inclusion of remdesivir in the therapeutic regimen.
JournalJournal of Internal Medicine
Publication classificationC1 Refereed article in a scholarly journal
Read the peer-reviewed publication
COVID-19General & Internal MedicineLife Sciences & BiomedicineMedicine, General & InternalmyelitisneurotropismSARS-COV-2Science & TechnologyAgedFemaleHumansMethylprednisoloneMyelitis, TransverseSARS-CoV-2PneumoniaLungVaccine RelatedPreventionBiodefenseRare DiseasesPneumonia & InfluenzaEmerging Infectious DiseasesInfectious DiseasesInfection